- Benson, Al B;
- D'Angelica, Michael I;
- Abbott, Daniel E;
- Abrams, Thomas A;
- Alberts, Steven R;
- Saenz, Daniel Anaya;
- Are, Chandrakanth;
- Brown, Daniel B;
- Chang, Daniel T;
- Covey, Anne M;
- Hawkins, William;
- Iyer, Renuka;
- Jacob, Rojymon;
- Karachristos, Andrea;
- Kelley, R Kate;
- Kim, Robin;
- Palta, Manisha;
- Park, James O;
- Sahai, Vaibhav;
- Schefter, Tracey;
- Schmidt, Carl;
- Sicklick, Jason K;
- Singh, Gagandeep;
- Sohal, Davendra;
- Stein, Stacey;
- Tian, G Gary;
- Vauthey, Jean-Nicolas;
- Venook, Alan P;
- Zhu, Andrew X;
- Hoffmann, Karin G;
- Darlow, Susan
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.
